The activity in vitro and in vivo of a new imidazole antifungal, ketoconazole.
D000818:Animals; D000935:Antifungal Agents / Q000627:therapeutic use; D003883:Arthrodermataceae / Q000187:drug effects; D001230:Aspergillus / Q000187:drug effects; D002177:Candidiasis / Q000188:drug therapy; D003881:Dermatomycoses / Q000188:drug therapy / Q000473:pathology; D005658:Fungi / Q000187:drug effects*; D006168:Guinea Pigs; D007093:Imidazoles / Q000494:pharmacology* / Q000627:therapeutic use; D007654:Ketoconazole; D008826:Microbial Sensitivity Tests; D010879:Piperazines / Q000494:pharmacology* / Q000627:therapeutic use; D013997:Time Factors
D000935:Antifungal Agents; D007093:Imidazoles; D010879:Piperazines; D007654:Ketoconazole